APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Sufentanil (API)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Sufentanil (API) Market Analysis and Forecast 2026-2032

Report ID 174038320221 December 2025199 pages

Choose your research edition.

Industry ResearchSufentanil (API) Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Sufentanil (API) Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Sufentanil (API) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sufentanil (API) Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Sufentanil (API) Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Sufentanil (API) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Sufentanil (API) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Sufentanil (API) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Sufentanil (API) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Sufentanil (API) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Sufentanil (API) include Janssen Pharmaceuticals, Kern Pharma, Hameln Rds, Cristalia and Cambrex, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Sufentanil (API), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Sufentanil (API), also provides the sales of main regions and countries. Of the upcoming market potential for Sufentanil (API), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Sufentanil (API) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Sufentanil (API) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Sufentanil (API) sales, projected growth trends, production technology, application and end-user industry.

Sufentanil (API) Segment by Company

Janssen Pharmaceuticals

Kern Pharma

Hameln Rds

Cristalia

Cambrex

Sufentanil (API) Segment by Type

Purity 98%

Purity 99%

Sufentanil (API) Segment by Application

Injection

Capsule

Sufentanil (API) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sufentanil (API) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sufentanil (API) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sufentanil (API).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Sufentanil (API) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Sufentanil (API) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sufentanil (API) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Sufentanil (API) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Purity 98% Major Manufacturers Table 3. Purity 99% Major Manufacturers Table 4. Global Sufentanil (API) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Injection Major Manufacturers Table 6. Capsule Major Manufacturers Table 7. Sufentanil (API) Industry Trends Table 8. Sufentanil (API) Industry Drivers Table 9. Sufentanil (API) Industry Opportunities and Challenges Table 10. Sufentanil (API) Industry Restraints Table 11. Global Sufentanil (API) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Sufentanil (API) Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Sufentanil (API) Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Sufentanil (API) Revenue Market Share by Region (2021-2026) Table 15. Global Sufentanil (API) Revenue Market Share by Region (2027-2032) Table 16. Global Sufentanil (API) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 17. Global Sufentanil (API) Sales by Region (2021-2026) & (k units) Table 18. Global Sufentanil (API) Sales by Region (2027-2032) & (k units) Table 19. Global Sufentanil (API) Sales Market Share by Region (2021-2026) Table 20. Global Sufentanil (API) Sales Market Share by Region (2027-2032) Table 21. Global Sufentanil (API) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Sufentanil (API) Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Sufentanil (API) Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Sufentanil (API) Sales Market Share by Manufacturers (2021-2026) Table 25. Global Sufentanil (API) Sales Price (US$/unit) of Manufacturers (2021-2026) Table 26. Global Sufentanil (API) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Sufentanil (API) Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Sufentanil (API) Manufacturers, Product Type & Application Table 29. Global Sufentanil (API) Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Sufentanil (API) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Sufentanil (API) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Sufentanil (API) Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Sufentanil (API) Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Sufentanil (API) Revenue Market Share by Type (2021-2026) Table 36. Global Sufentanil (API) Revenue Market Share by Type (2027-2032) Table 37. Global Sufentanil (API) Sales by Type 2021 VS 2025 VS 2032 (k units) Table 38. Global Sufentanil (API) Sales by Type (2021-2026) & (k units) Table 39. Global Sufentanil (API) Sales by Type (2027-2032) & (k units) Table 40. Global Sufentanil (API) Sales Market Share by Type (2021-2026) Table 41. Global Sufentanil (API) Sales Market Share by Type (2027-2032) Table 42. Global Sufentanil (API) Price by Type (2021-2026) & (US$/unit) Table 43. Global Sufentanil (API) Price by Type (2027-2032) & (US$/unit) Table 44. Global Sufentanil (API) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Sufentanil (API) Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Sufentanil (API) Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Sufentanil (API) Revenue Market Share by Application (2021-2026) Table 48. Global Sufentanil (API) Revenue Market Share by Application (2027-2032) Table 49. Global Sufentanil (API) Sales by Application 2021 VS 2025 VS 2032 (k units) Table 50. Global Sufentanil (API) Sales by Application (2021-2026) & (k units) Table 51. Global Sufentanil (API) Sales by Application (2027-2032) & (k units) Table 52. Global Sufentanil (API) Sales Market Share by Application (2021-2026) Table 53. Global Sufentanil (API) Sales Market Share by Application (2027-2032) Table 54. Global Sufentanil (API) Price by Application (2021-2026) & (US$/unit) Table 55. Global Sufentanil (API) Price by Application (2027-2032) & (US$/unit) Table 56. Janssen Pharmaceuticals Company Information Table 57. Janssen Pharmaceuticals Business Overview Table 58. Janssen Pharmaceuticals Sufentanil (API) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 59. Janssen Pharmaceuticals Sufentanil (API) Product Portfolio Table 60. Janssen Pharmaceuticals Recent Development Table 61. Kern Pharma Company Information Table 62. Kern Pharma Business Overview Table 63. Kern Pharma Sufentanil (API) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 64. Kern Pharma Sufentanil (API) Product Portfolio Table 65. Kern Pharma Recent Development Table 66. Hameln Rds Company Information Table 67. Hameln Rds Business Overview Table 68. Hameln Rds Sufentanil (API) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Hameln Rds Sufentanil (API) Product Portfolio Table 70. Hameln Rds Recent Development Table 71. Cristalia Company Information Table 72. Cristalia Business Overview Table 73. Cristalia Sufentanil (API) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Cristalia Sufentanil (API) Product Portfolio Table 75. Cristalia Recent Development Table 76. Cambrex Company Information Table 77. Cambrex Business Overview Table 78. Cambrex Sufentanil (API) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Cambrex Sufentanil (API) Product Portfolio Table 80. Cambrex Recent Development Table 81. North America Sufentanil (API) Revenue by Type (2021-2026) & (US$ Million) Table 82. North America Sufentanil (API) Revenue by Type (2027-2032) & (US$ Million) Table 83. North America Sufentanil (API) Sales by Type (2021-2026) & (k units) Table 84. North America Sufentanil (API) Sales by Type (2027-2032) & (k units) Table 85. North America Sufentanil (API) Sales Price by Type (2021-2026) & (US$/unit) Table 86. North America Sufentanil (API) Sales Price by Type (2027-2032) & (US$/unit) Table 87. North America Sufentanil (API) Revenue by Application (2021-2026) & (US$ Million) Table 88. North America Sufentanil (API) Revenue by Application (2027-2032) & (US$ Million) Table 89. North America Sufentanil (API) Sales by Application (2021-2026) & (k units) Table 90. North America Sufentanil (API) Sales by Application (2027-2032) & (k units) Table 91. North America Sufentanil (API) Sales Price by Application (2021-2026) & (US$/unit) Table 92. North America Sufentanil (API) Sales Price by Application (2027-2032) & (US$/unit) Table 93. North America Sufentanil (API) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. North America Sufentanil (API) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 95. North America Sufentanil (API) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 96. North America Sufentanil (API) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 97. North America Sufentanil (API) Sales by Country (2021-2026) & (k units) Table 98. North America Sufentanil (API) Sales by Country (2027-2032) & (k units) Table 99. North America Sufentanil (API) Sales Price by Country (2021-2026) & (US$/unit) Table 100. North America Sufentanil (API) Sales Price by Country (2027-2032) & (US$/unit) Table 101. United States Sufentanil (API) Revenue (2021-2032) & (US$ Million) Table 102. Canada Sufentanil (API) Revenue (2021-2032) & (US$ Million) Table 103. Mexico Sufentanil (API) Revenue (2021-2032) & (US$ Million) Table 104. Europe Sufentanil (API) Revenue by Type (2021-2026) & (US$ Million) Table 105. Europe Sufentanil (API) Revenue by Type (2027-2032) & (US$ Million) Table 106. Europe Sufentanil (API) Sales by Type (2021-2026) & (k units) Table 107. Europe Sufentanil (API) Sales by Type (2027-2032) & (k units) Table 108. Europe Sufentanil (API) Sales Price by Type (2021-2026) & (US$/unit) Table 109. Europe Sufentanil (API) Sales Price by Type (2027-2032) & (US$/unit) Table 110. Europe Sufentanil (API) Revenue by Application (2021-2026) & (US$ Million) Table 111. Europe Sufentanil (API) Revenue by Application (2027-2032) & (US$ Million) Table 112. Europe Sufentanil (API) Sales by Application (2021-2026) & (k units) Table 113. Europe Sufentanil (API) Sales by Application (2027-2032) & (k units) Table 114. Europe Sufentanil (API) Sales Price by Application (2021-2026) & (US$/unit) Table 115. Europe Sufentanil (API) Sales Price by Application (2027-2032) & (US$/unit) Table 116. Europe Sufentanil (API) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Europe Sufentanil (API) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 118. Europe Sufentanil (API) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 119. Europe Sufentanil (API) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 120. Europe Sufentanil (API) Sales by Country (2021-2026) & (k units) Table 121. Europe Sufentanil (API) Sales by Country (2027-2032) & (k units) Table 122. Europe Sufentanil (API) Sales Price by Country (2021-2026) & (US$/unit) Table 123. Europe Sufentanil (API) Sales Price by Country (2027-2032) & (US$/unit) Table 124. Germany Sufentanil (API) Revenue (2021-2032) & (US$ Million) Table 125. France Sufentanil (API) Revenue (2021-2032) & (US$ Million) Table 126. U.K. Sufentanil (API) Revenue (2021-2032) & (US$ Million) Table 127. Italy Sufentanil (API) Revenue (2021-2032) & (US$ Million) Table 128. Russia Sufentanil (API) Revenue (2021-2032) & (US$ Million) Table 129. Spain Sufentanil (API) Revenue (2021-2032) & (US$ Million) Table 130. Netherlands Sufentanil (API) Revenue (2021-2032) & (US$ Million) Table 131. Switzerland Sufentanil (API) Revenue (2021-2032) & (US$ Million) Table 132. Sweden Sufentanil (API) Revenue (2021-2032) & (US$ Million) Table 133. Poland Sufentanil (API) Revenue (2021-2032) & (US$ Million) Table 134. China Sufentanil (API) Revenue by Type (2021-2026) & (US$ Million) Table 135. China Sufentanil (API) Revenue by Type (2027-2032) & (US$ Million) Table 136. China Sufentanil (API) Sales by Type (2021-2026) & (k units) Table 137. China Sufentanil (API) Sales by Type (2027-2032) & (k units) Table 138. China Sufentanil (API) Sales Price by Type (2021-2026) & (US$/unit) Table 139. China Sufentanil (API) Sales Price by Type (2027-2032) & (US$/unit) Table 140. China Sufentanil (API) Revenue by Application (2021-2026) & (US$ Million) Table 141. China Sufentanil (API) Revenue by Application (2027-2032) & (US$ Million) Table 142. China Sufentanil (API) Sales by Application (2021-2026) & (k units) Table 143. China Sufentanil (API) Sales by Application (2027-2032) & (k units) Table 144. China Sufentanil (API) Sales Price by Application (2021-2026) & (US$/unit) Table 145. China Sufentanil (API) Sales Price by Application (2027-2032) & (US$/unit) Table 146. Asia Sufentanil (API) Revenue by Type (2021-2026) & (US$ Million) Table 147. Asia Sufentanil (API) Revenue by Type (2027-2032) & (US$ Million) Table 148. Asia Sufentanil (API) Sales by Type (2021-2026) & (k units) Table 149. Asia Sufentanil (API) Sales by Type (2027-2032) & (k units) Table 150. Asia Sufentanil (API) Sales Price by Type (2021-2026) & (US$/unit) Table 151. Asia Sufentanil (API) Sales Price by Type (2027-2032) & (US$/unit) Table 152. Asia Sufentanil (API) Revenue by Application (2021-2026) & (US$ Million) Table 153. Asia Sufentanil (API) Revenue by Application (2027-2032) & (US$ Million) Table 154. Asia Sufentanil (API) Sales by Application (2021-2026) & (k units) Table 155. Asia Sufentanil (API) Sales by Application (2027-2032) & (k units) Table 156. Asia Sufentanil (API) Sales Price by Application (2021-2026) & (US$/unit) Table 157. Asia Sufentanil (API) Sales Price by Application (2027-2032) & (US$/unit) Table 158. Asia Sufentanil (API) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Asia Sufentanil (API) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. Asia Sufentanil (API) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. Asia Sufentanil (API) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 162. Asia Sufentanil (API) Sales by Country (2021-2026) & (k units) Table 163. Asia Sufentanil (API) Sales by Country (2027-2032) & (k units) Table 164. Asia Sufentanil (API) Sales Price by Country (2021-2026) & (US$/unit) Table 165. Asia Sufentanil (API) Sales Price by Country (2027-2032) & (US$/unit) Table 166. Japan Sufentanil (API) Revenue (2021-2032) & (US$ Million) Table 167. South Korea Sufentanil (API) Revenue (2021-2032) & (US$ Million) Table 168. India Sufentanil (API) Revenue (2021-2032) & (US$ Million) Table 169. Australia Sufentanil (API) Revenue (2021-2032) & (US$ Million) Table 170. Taiwan Sufentanil (API) Revenue (2021-2032) & (US$ Million) Table 171. Southeast Asia Sufentanil (API) Revenue (2021-2032) & (US$ Million) Table 172. SAMEA Sufentanil (API) Revenue by Type (2021-2026) & (US$ Million) Table 173. SAMEA Sufentanil (API) Revenue by Type (2027-2032) & (US$ Million) Table 174. SAMEA Sufentanil (API) Sales by Type (2021-2026) & (k units) Table 175. SAMEA Sufentanil (API) Sales by Type (2027-2032) & (k units) Table 176. SAMEA Sufentanil (API) Sales Price by Type (2021-2026) & (US$/unit) Table 177. SAMEA Sufentanil (API) Sales Price by Type (2027-2032) & (US$/unit) Table 178. SAMEA Sufentanil (API) Revenue by Application (2021-2026) & (US$ Million) Table 179. SAMEA Sufentanil (API) Revenue by Application (2027-2032) & (US$ Million) Table 180. SAMEA Sufentanil (API) Sales by Application (2021-2026) & (k units) Table 181. SAMEA Sufentanil (API) Sales by Application (2027-2032) & (k units) Table 182. SAMEA Sufentanil (API) Sales Price by Application (2021-2026) & (US$/unit) Table 183. SAMEA Sufentanil (API) Sales Price by Application (2027-2032) & (US$/unit) Table 184. SAMEA Sufentanil (API) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. SAMEA Sufentanil (API) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. SAMEA Sufentanil (API) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. SAMEA Sufentanil (API) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 188. SAMEA Sufentanil (API) Sales by Country (2021-2026) & (k units) Table 189. SAMEA Sufentanil (API) Sales by Country (2027-2032) & (k units) Table 190. SAMEA Sufentanil (API) Sales Price by Country (2021-2026) & (US$/unit) Table 191. SAMEA Sufentanil (API) Sales Price by Country (2027-2032) & (US$/unit) Table 192. Brazil Sufentanil (API) Revenue (2021-2032) & (US$ Million) Table 193. Argentina Sufentanil (API) Revenue (2021-2032) & (US$ Million) Table 194. Chile Sufentanil (API) Revenue (2021-2032) & (US$ Million) Table 195. Colombia Sufentanil (API) Revenue (2021-2032) & (US$ Million) Table 196. Peru Sufentanil (API) Revenue (2021-2032) & (US$ Million) Table 197. Saudi Arabia Sufentanil (API) Revenue (2021-2032) & (US$ Million) Table 198. Israel Sufentanil (API) Revenue (2021-2032) & (US$ Million) Table 199. UAE Sufentanil (API) Revenue (2021-2032) & (US$ Million) Table 200. Turkey Sufentanil (API) Revenue (2021-2032) & (US$ Million) Table 201. Iran Sufentanil (API) Revenue (2021-2032) & (US$ Million) Table 202. Egypt Sufentanil (API) Revenue (2021-2032) & (US$ Million) Table 203. Key Raw Materials Table 204. Raw Materials Key Suppliers Table 205. Sufentanil (API) Distributors List Table 206. Sufentanil (API) Customers List Table 207. Research Programs/Design for This Report Table 208. Authors List of This Report Table 209. Secondary Sources Table 210. Primary Sources List of Figures Figure 1. Sufentanil (API) Image Figure 2. Global Sufentanil (API) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sufentanil (API) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Purity 98% Image Figure 5. Purity 99% Image Figure 6. Global Sufentanil (API) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Sufentanil (API) Market Size Share 2021 VS 2025 VS 2032 Figure 8. Injection Image Figure 9. Capsule Image Figure 10. Global Sufentanil (API) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Sufentanil (API) Revenue (2021-2032) & (US$ Million) Figure 12. Global Sufentanil (API) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Sufentanil (API) Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Sufentanil (API) Revenue Market Share by Region (2021-2032) Figure 15. Global Sufentanil (API) Sales (2021-2032) & (k units) Figure 16. Global Sufentanil (API) Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 17. Global Sufentanil (API) Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Sufentanil (API) Sales YoY (2021-2032) & (k units) Figure 19. Europe Sufentanil (API) Sales YoY (2021-2032) & (k units) Figure 20. China Sufentanil (API) Sales YoY (2021-2032) & (k units) Figure 21. Asia (Excluding China) Sufentanil (API) Sales YoY (2021-2032) & (k units) Figure 22. South America, Middle East and Africa Sufentanil (API) Sales YoY (2021-2032) & (k units) Figure 23. Global Sufentanil (API) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Sufentanil (API) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Sufentanil (API) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Sufentanil (API) Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Sufentanil (API) Revenue Market Share by Type (2021-2032) Figure 29. Global Sufentanil (API) Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 30. Global Sufentanil (API) Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Sufentanil (API) Sales Market Share by Type (2021-2032) Figure 32. Global Sufentanil (API) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Sufentanil (API) Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Sufentanil (API) Revenue Market Share by Application (2021-2032) Figure 35. Global Sufentanil (API) Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 36. Global Sufentanil (API) Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Sufentanil (API) Sales Market Share by Application (2021-2032) Figure 38. North America Sufentanil (API) Revenue Share by Type (2021-2032) Figure 39. North America Sufentanil (API) Sales Share by Type (2021-2032) Figure 40. North America Sufentanil (API) Revenue Share by Application (2021-2032) Figure 41. North America Sufentanil (API) Sales Share by Application (2021-2032) Figure 42. North America Sufentanil (API) Revenue Share by Country (2021-2032) Figure 43. North America Sufentanil (API) Sales Share by Country (2021-2032) Figure 44. Europe Sufentanil (API) Revenue Share by Type (2021-2032) Figure 45. Europe Sufentanil (API) Sales Share by Type (2021-2032) Figure 46. Europe Sufentanil (API) Revenue Share by Application (2021-2032) Figure 47. Europe Sufentanil (API) Sales Share by Application (2021-2032) Figure 48. Europe Sufentanil (API) Revenue Share by Country (2021-2032) Figure 49. Europe Sufentanil (API) Sales Share by Country (2021-2032) Figure 50. China Sufentanil (API) Revenue Share by Type (2021-2032) Figure 51. China Sufentanil (API) Sales Share by Type (2021-2032) Figure 52. China Sufentanil (API) Revenue Share by Application (2021-2032) Figure 53. China Sufentanil (API) Sales Share by Application (2021-2032) Figure 54. Asia Sufentanil (API) Revenue Share by Type (2021-2032) Figure 55. Asia Sufentanil (API) Sales Share by Type (2021-2032) Figure 56. Asia Sufentanil (API) Revenue Share by Application (2021-2032) Figure 57. Asia Sufentanil (API) Sales Share by Application (2021-2032) Figure 58. Asia Sufentanil (API) Revenue Share by Country (2021-2032) Figure 59. Asia Sufentanil (API) Sales Share by Country (2021-2032) Figure 60. SAMEA Sufentanil (API) Revenue Share by Type (2021-2032) Figure 61. SAMEA Sufentanil (API) Sales Share by Type (2021-2032) Figure 62. SAMEA Sufentanil (API) Revenue Share by Application (2021-2032) Figure 63. SAMEA Sufentanil (API) Sales Share by Application (2021-2032) Figure 64. SAMEA Sufentanil (API) Revenue Share by Country (2021-2032) Figure 65. SAMEA Sufentanil (API) Sales Share by Country (2021-2032) Figure 66. Sufentanil (API) Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Sufentanil (API) Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Purity 98%
  • Purity 99%
Applications
  • Injection
  • Capsule
Companies covered
  • Janssen Pharmaceuticals
  • Kern Pharma
  • Hameln Rds
  • Cristalia
  • Cambrex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Sufentanil (API) Market by Type
  3. 1.2.1 Global Sufentanil (API) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Purity 98%
  5. 1.2.3 Purity 99%
  6. 1.3 Sufentanil (API) Market by Application
  7. 1.3.1 Global Sufentanil (API) Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Injection
  9. 1.3.3 Capsule
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Sufentanil (API) Market Dynamics
  1. 2.1 Sufentanil (API) Industry Trends
  2. 2.2 Sufentanil (API) Industry Drivers
  3. 2.3 Sufentanil (API) Industry Opportunities and Challenges
  4. 2.4 Sufentanil (API) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Sufentanil (API) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Sufentanil (API) Revenue by Region
  3. 3.2.1 Global Sufentanil (API) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Sufentanil (API) Revenue by Region (2021-2026)
  5. 3.2.3 Global Sufentanil (API) Revenue by Region (2027-2032)
  6. 3.2.4 Global Sufentanil (API) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Sufentanil (API) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Sufentanil (API) Sales by Region
  9. 3.4.1 Global Sufentanil (API) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Sufentanil (API) Sales by Region (2021-2026)
  11. 3.4.3 Global Sufentanil (API) Sales by Region (2027-2032)
  12. 3.4.4 Global Sufentanil (API) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Sufentanil (API) Revenue by Manufacturers
  2. 4.1.1 Global Sufentanil (API) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Sufentanil (API) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Sufentanil (API) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Sufentanil (API) Sales by Manufacturers
  6. 4.2.1 Global Sufentanil (API) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Sufentanil (API) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Sufentanil (API) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Sufentanil (API) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Sufentanil (API) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Sufentanil (API) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Sufentanil (API) Manufacturers, Product Type & Application
  13. 4.7 Global Sufentanil (API) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Sufentanil (API) Market CR5 and HHI
  16. 4.8.2 2025 Sufentanil (API) Tier 1, Tier 2, and Tier 3
5 Sufentanil (API) Market by Type
  1. 5.1 Global Sufentanil (API) Revenue by Type
  2. 5.1.1 Global Sufentanil (API) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Sufentanil (API) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Sufentanil (API) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Sufentanil (API) Sales by Type
  6. 5.2.1 Global Sufentanil (API) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Sufentanil (API) Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Sufentanil (API) Sales Market Share by Type (2021-2032)
  9. 5.3 Global Sufentanil (API) Price by Type
6 Sufentanil (API) Market by Application
  1. 6.1 Global Sufentanil (API) Revenue by Application
  2. 6.1.1 Global Sufentanil (API) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Sufentanil (API) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Sufentanil (API) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Sufentanil (API) Sales by Application
  6. 6.2.1 Global Sufentanil (API) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Sufentanil (API) Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Sufentanil (API) Sales Market Share by Application (2021-2032)
  9. 6.3 Global Sufentanil (API) Price by Application
7 Company Profiles
  1. 7.1 Janssen Pharmaceuticals
  2. 7.1.1 Janssen Pharmaceuticals Company Information
  3. 7.1.2 Janssen Pharmaceuticals Business Overview
  4. 7.1.3 Janssen Pharmaceuticals Sufentanil (API) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Janssen Pharmaceuticals Sufentanil (API) Product Portfolio
  6. 7.1.5 Janssen Pharmaceuticals Recent Developments
  7. 7.2 Kern Pharma
  8. 7.2.1 Kern Pharma Company Information
  9. 7.2.2 Kern Pharma Business Overview
  10. 7.2.3 Kern Pharma Sufentanil (API) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Kern Pharma Sufentanil (API) Product Portfolio
  12. 7.2.5 Kern Pharma Recent Developments
  13. 7.3 Hameln Rds
  14. 7.3.1 Hameln Rds Company Information
  15. 7.3.2 Hameln Rds Business Overview
  16. 7.3.3 Hameln Rds Sufentanil (API) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Hameln Rds Sufentanil (API) Product Portfolio
  18. 7.3.5 Hameln Rds Recent Developments
  19. 7.4 Cristalia
  20. 7.4.1 Cristalia Company Information
  21. 7.4.2 Cristalia Business Overview
  22. 7.4.3 Cristalia Sufentanil (API) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Cristalia Sufentanil (API) Product Portfolio
  24. 7.4.5 Cristalia Recent Developments
  25. 7.5 Cambrex
  26. 7.5.1 Cambrex Company Information
  27. 7.5.2 Cambrex Business Overview
  28. 7.5.3 Cambrex Sufentanil (API) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Cambrex Sufentanil (API) Product Portfolio
  30. 7.5.5 Cambrex Recent Developments
8 North America
  1. 8.1 North America Sufentanil (API) Market Size by Type
  2. 8.1.1 North America Sufentanil (API) Revenue by Type (2021-2032)
  3. 8.1.2 North America Sufentanil (API) Sales by Type (2021-2032)
  4. 8.1.3 North America Sufentanil (API) Price by Type (2021-2032)
  5. 8.2 North America Sufentanil (API) Market Size by Application
  6. 8.2.1 North America Sufentanil (API) Revenue by Application (2021-2032)
  7. 8.2.2 North America Sufentanil (API) Sales by Application (2021-2032)
  8. 8.2.3 North America Sufentanil (API) Price by Application (2021-2032)
  9. 8.3 North America Sufentanil (API) Market Size by Country
  10. 8.3.1 North America Sufentanil (API) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Sufentanil (API) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Sufentanil (API) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Sufentanil (API) Market Size by Type
  2. 9.1.1 Europe Sufentanil (API) Revenue by Type (2021-2032)
  3. 9.1.2 Europe Sufentanil (API) Sales by Type (2021-2032)
  4. 9.1.3 Europe Sufentanil (API) Price by Type (2021-2032)
  5. 9.2 Europe Sufentanil (API) Market Size by Application
  6. 9.2.1 Europe Sufentanil (API) Revenue by Application (2021-2032)
  7. 9.2.2 Europe Sufentanil (API) Sales by Application (2021-2032)
  8. 9.2.3 Europe Sufentanil (API) Price by Application (2021-2032)
  9. 9.3 Europe Sufentanil (API) Market Size by Country
  10. 9.3.1 Europe Sufentanil (API) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Sufentanil (API) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Sufentanil (API) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Sufentanil (API) Market Size by Type
  2. 10.1.1 China Sufentanil (API) Revenue by Type (2021-2032)
  3. 10.1.2 China Sufentanil (API) Sales by Type (2021-2032)
  4. 10.1.3 China Sufentanil (API) Price by Type (2021-2032)
  5. 10.2 China Sufentanil (API) Market Size by Application
  6. 10.2.1 China Sufentanil (API) Revenue by Application (2021-2032)
  7. 10.2.2 China Sufentanil (API) Sales by Application (2021-2032)
  8. 10.2.3 China Sufentanil (API) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Sufentanil (API) Market Size by Type
  2. 11.1.1 Asia Sufentanil (API) Revenue by Type (2021-2032)
  3. 11.1.2 Asia Sufentanil (API) Sales by Type (2021-2032)
  4. 11.1.3 Asia Sufentanil (API) Price by Type (2021-2032)
  5. 11.2 Asia Sufentanil (API) Market Size by Application
  6. 11.2.1 Asia Sufentanil (API) Revenue by Application (2021-2032)
  7. 11.2.2 Asia Sufentanil (API) Sales by Application (2021-2032)
  8. 11.2.3 Asia Sufentanil (API) Price by Application (2021-2032)
  9. 11.3 Asia Sufentanil (API) Market Size by Country
  10. 11.3.1 Asia Sufentanil (API) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Sufentanil (API) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Sufentanil (API) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Sufentanil (API) Market Size by Type
  2. 12.1.1 SAMEA Sufentanil (API) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Sufentanil (API) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Sufentanil (API) Price by Type (2021-2032)
  5. 12.2 SAMEA Sufentanil (API) Market Size by Application
  6. 12.2.1 SAMEA Sufentanil (API) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Sufentanil (API) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Sufentanil (API) Price by Application (2021-2032)
  9. 12.3 SAMEA Sufentanil (API) Market Size by Country
  10. 12.3.1 SAMEA Sufentanil (API) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Sufentanil (API) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Sufentanil (API) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Sufentanil (API) Value Chain Analysis
  2. 13.1.1 Sufentanil (API) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Sufentanil (API) Production Mode & Process
  6. 13.2 Sufentanil (API) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Sufentanil (API) Distributors
  9. 13.2.3 Sufentanil (API) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst